Fibronectin promotes the proliferation of cytotoxic T lymphocytes generated from cancer patients
1996

Fibronectin and T Lymphocyte Growth in Cancer Patients

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): S Mizobata, H Tanimura, H Yamaue, M Tani, T Tsunoda, M Iwahashi, K Noguchi, N Nishimoto, T Hotta, K Arii

Primary Institution: Wakayama Medical School

Hypothesis

Does fibronectin enhance the activity of cytotoxic T lymphocytes generated from cancer patients?

Conclusion

Fibronectin significantly enhances the proliferation and cytotoxic activity of T lymphocytes in cancer patients.

Supporting Evidence

  • Fibronectin increased the proliferation of T lymphocytes by three to four times.
  • CTLs stimulated by fibronectin showed significantly higher cytotoxic activity against autologous tumor cells.
  • Production of cytokines like IL-2 and IFN-y was significantly increased with fibronectin stimulation.

Takeaway

Fibronectin helps special immune cells called T lymphocytes grow and fight cancer better.

Methodology

The study involved obtaining peripheral blood mononuclear cells from cancer patients and stimulating them with immobilized anti-CD3 monoclonal antibody and interleukin 2, with and without fibronectin.

Participant Demographics

Patients with various types of malignant diseases including thyroid, gastric, duodenal, colonic, gallbladder cancers, and others.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication